We’re delighted to welcome Professor Saye Khoo, Professor of Pharmacology and Therapeutics at the University of Liverpool and Honorary Consultant Physician in Infectious Disease at Liverpool University Hospitals NHS Foundation Trust, who will be presenting at our upcoming PSI seminar. Professor Khoo leads a research programme in antiviral therapy and is Chief Investigator for the international DolPHIN consortium and the AGILE platform. His work focuses on optimising antivirals to treat or prevent HIV, including in special populations such as pregnant women and newborn infants.

The seminar will be chaired by Khiyam Hussain and it will take place from 12:30 to 13:30 in the lecture theatre, Richard Doll Building. This will be followed by a networking session, during which lunch will be provided.

Abstract
Professor Saye Khoo and his team’s work is underpinned by highly sensitive drug measurements within their GCP-accredited laboratory. By combining this with advanced mathematical modelling, they are able to predict drug exposure across different body compartments and individuals. Their work on drug-drug interactions led to the creation of the Liverpool Drug Interactions Prescribing Resource, which supports clinical decision-making in the treatment of HIV, hepatitis, cancer and since 2020, experimental COVID-19 therapies. This resource is globally recognised and widely integrated into treatment guidelines, including those of the World Health Organization, receiving over 18 million searches in the past three years.

Biography
Saye Khoo is Professor of Pharmacology and Therapeutics at the University of Liverpool and Honorary Consultant Physician in Infectious Diseases at Liverpool University Hospitals NHS Foundation Trust. He leads a research programme focused on antiviral therapy and serves as Chief Investigator for both the international DolPHIN consortium and the AGILE platform. His research centres on optimising antiviral treatments, particularly for the prevention and management of HIV. A key aspect of his work, understanding drug–drug interactions, led to the creation of the Liverpool Drug Interactions Prescribing Resource, a globally recognised tool supporting clinical decision-making in HIV, hepatitis, cancer, and, since 2020, experimental COVID-19 therapies. Professor Khoo has served on expert advisory groups and guideline committees for a range of national and international organisations, including the British HIV Association, World Health Organization, British Infection Society, UK Home Office, and the International AIDS Society.